RA-ILD: Tracking Function and CT - Summary - MDSpire

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

  • By

  • Kathryn Wighton

  • March 6, 2026

  • 4 min

Share

Objective:

To describe the natural history of predominantly mild rheumatoid arthritis–associated interstitial lung disease (RA-ILD) and evaluate imaging markers over 2 years, highlighting their clinical significance.

Key Findings:
  • Pulmonary function and quantitative CT measures remained stable over 24 months, despite an 8% mortality rate, which is noteworthy as deaths were not preceded by measurable decline in FVC or imaging parameters.
  • 80% of participants had pulmonary fibrosis, but only 20% classified as definite or probable usual interstitial pneumonia.
Interpretation:

The findings challenge the conventional paradigm in ILD where functional decline typically precedes death, suggesting a need for further investigation into the clinical implications of these results.

Limitations:
  • Modest sample size and missing follow-up data due to the COVID-19 pandemic, which may affect the generalizability of the findings.
  • Limited mortality events constrain definitive conclusions about prognostic performance.
Conclusion:

The study highlights the stability of pulmonary function in RA-ILD over 24 months despite mortality, warranting further research to explore the underlying mechanisms.

Original Source(s)

RA-ILD: Tracking Function and CT

  • by Kathryn Wighton

  • March 6, 2026

Related Content

Three Genes May Help Distinguish RA From OA

Machine learning and cell-line validation identify candidate biomarkers for differentiating rheumatoid arthritis vs osteoarthritis

Side Effects: Salt, Steroids, and Second Brains

So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.